Wockhardt Group

Rediff.com » News » Wockhardt Group

News for Wockhardt Group

News
Business

The Coming Dementia Epidemic

Around 7.4 per cent of Indians aged 60 and above are affected by dementia.This number is expected to rise from the current 8.8 million to 17 million by 2036, marking a 97 per cent increase. Kindly......

Oxford/AstraZeneca COVID-19 vaccine approved by UK regulator

The coronavirus vaccine designed by scientists at the University of Oxford and produced by AstraZeneca was on Wednesday approved for human use by the United Kingdom’s independent regulator.......

As India learns to 'live' with COVID-19, hospitals brace for new normal

Most feel as the movement of people normalises, the in-patient volumes in hospitals will grow and by the end of May, occupancy should be around 50 per cent, and 75 per cent over a period of time.......

The real threat to India's democracy

'If one observes a common man passing a church or gurdwara or dargah, he instinctively bows his head. It is this prevalence of polytheism that has ensured that monotheists and minorities flourish......

Ministers Still CONTROL Business!

Indian businesses' weak ability to compete overseas says much about the infirmities imposed by the intensity of government dominance of economic policy and the nature of this dominance, observes......

Home healthcare could be one of India's best bets

One of the biggest impediments to growth for this sector is the fact that home healthcare in India is not covered by insurance. In Delhi’s Greater Kailash, Alka Sahni began to panic as her......

10 large caps for good returns in 2021

Investment in market leaders with a safety-first approach could yield reasonable returns across sectors.Ram Prasad Sahu and Hamsini Karthik report. Photograph: Adnan Abidi/Reuters A sharp......

Covid-19 could be the boost Indian pharma cos need

The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and......

Dr Reddy's to launch Covid drugs remdesivir and favipiravir in August

Apart from favipiravir and remdesivir, its key Covid-19 products, DRL has already launched nutraceutical products and hand sanitisers during the pandemic. IMAGE: Health workers wearing PPE kits......

Rediff News

Wockhardt Group

News for Wockhardt Group

The Coming Dementia Epidemic

Oxford/AstraZeneca COVID-19 vaccine approved by UK regulator

As India learns to 'live' with COVID-19, hospitals brace for new normal

The real threat to India's democracy

Ministers Still CONTROL Business!

Home healthcare could be one of India's best bets

10 large caps for good returns in 2021

Covid-19 could be the boost Indian pharma cos need

Dr Reddy's to launch Covid drugs remdesivir and favipiravir in August

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS